Amparo C. M.
- Country
- Spain
- Department
- Internal Medicine
Research Overview
Data & Insights
Has run more than one trial at 1 of 55 partner sites.
Specializations
Thoracic Oncology
Amparo Carrasco Mas is involved in clinical research centered on non-small cell lung cancer and small cell lung cancer, with interest in advanced, metastatic, and unresectable disease settings. The portfolio also extends to molecularly defined lung cancer populations, including EGFR exon 20 insertion and KRAS G12C alterations.
- Advanced and metastatic NSCLC
- EGFR-altered lung cancer
- KRAS G12C-mutant solid tumours
- Resectable and locally advanced lung cancer
Her work also includes immunotherapy combinations and targeted approaches aimed at improving disease control in lung cancer.
Breast Cancer and Gynecologic Oncology
Her clinical trial activity includes a strong focus on breast cancer, especially metastatic breast cancer, HER2-positive, HER2-low, and hormone receptor-positive disease. She is also engaged in research across ovarian cancer, cervical cancer, and endometrial carcinoma.
- Triple-negative breast cancer
- HER2-positive and HER2-low breast cancer
- Ovarian cancer
- Cervical and endometrial malignancies
Her research landscape also includes neoadjuvant, adjuvant, and metastatic treatment strategies in women’s cancers.
Gastrointestinal, Pancreatic, and Urothelial Cancers
She is active in studies involving colorectal cancer, gastric cancer, esophageal cancer, and pancreatic ductal adenocarcinoma, with additional involvement in urothelial carcinoma and bladder cancer. These areas reflect a broad interest in advanced solid tumours with high unmet need.
- Colorectal cancer
- Gastric and gastroesophageal junction cancer
- Pancreatic ductal adenocarcinoma
- Urothelial carcinoma and bladder cancer
Her trial portfolio includes biomarker-defined and treatment-resistant disease populations in these gastrointestinal and genitourinary malignancies.
Head and Neck, Melanoma, and Other Solid Tumours
Her research also covers head and neck squamous cell carcinoma, melanoma, and broader solid tumours, including relapsed, refractory, and metastatic disease. This includes interest in tumors with actionable alterations such as BRAF V600 and FGFR3 changes, as well as TP53 Y220C mutation-associated cancers.
- Head and neck squamous cell carcinoma
- Malignant melanoma
- Advanced solid tumours
- Mutation-defined solid malignancies
Her involvement spans immunotherapy-based and targeted strategies across difficult-to-treat solid tumor settings.
Cardiometabolic and Renal Disease
In addition to oncology, Amparo Carrasco Mas participates in clinical research in atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, hypertension, and chronic kidney disease. Her portfolio also includes hypertriglyceridemia and type 2 diabetes mellitus-related renal disease.
- Cardiovascular disease
- Heart failure and atrial fibrillation
- Chronic kidney disease
- Hypertriglyceridemia and metabolic risk
She also contributes to research in cancer-associated thrombosis and other supportive-care domains linked to complex oncology populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.